The antiserum was produced against synthesized peptide derived from human c-PLA2 around the phosphorylation site of Ser505.
Alternative Names:
calcium-dependent phospholipid-binding protein,cPLA2,cPLA2-alpha,cytosolic phospholipase A2,GURDP,lysophospholipase,phosphatidylcholine 2-acylhydrolase,Phospholipase A2 group IVA,phospholipase A2, group IVA (cytosolic, calcium-dependent),PLA2G4.
Selectively hydrolyzes arachidonyl phospholipids in the sn-2 position releasing arachidonic acid. Together with its lysophospholipid activity, it is implicated in the initiation of the inflammatory response.
